Skip to main content
. Author manuscript; available in PMC: 2021 Nov 1.
Published in final edited form as: AIDS. 2020 Nov 1;34(13):1933–1941. doi: 10.1097/QAD.0000000000002654

Table 2.

Incidence of high-risk human papillomavirus types in HIV-positive and HIV-negative participants (N=264)

HIV-Positive (n=163) HIV-Negative (n=101)

HPV Type Baseline n(%) Incidence (number) Person-Months Incidence/1000 Person-Months (95% CI) 12-Month Incidence(%) (95% CI) Baseline n(%) Incidence (number) Person-Months Incidence/1000 Person-Months (95% CI) 12-Month Incidence(%) (95% CI) IRR (95% CI) p-value
 HPV16 40(18.9) 10 1460.6 6.8(3.7-12.7) 8.2(4.4-15.2) 18(13.6) 3 1074.0 2.8(0.9-8.7) 3.3(1.1-10.4) 2.5(0.6-13.9) 0.17
 HPV18 28(13.2) 7 1600.8 4.4(2.1-9.2) 5.2(2.5-11) 13(9.9) 2 1130.7 1.8(0.4-7.1) 2.1(0.5-8.5) 2.5(0.5-24.4) 0.27
 HPV31 10(4.7) 1 1796.7 0.6(0.1-4) 0.7(0.1-4.7) 2(1.5) 1 1241.3 0.8(0.1-5.7) 1(0.1-6.8) 0.7(0-54.2) 0.82
 HPV33 13(6.1) 2 1732.3 1.2(0.3-4.6) 1.4(0.3-5.5) 0(0) 0 0.0 0(0-0) 0(0-0)
 HPV35 9(4.3) 1 1775.1 0.6(0.1-4) 0.7(0.1-4.8) 1(0.8) 0 0.0 0(0-0) 0(0-0)
 HPV39 17(8) 4 1675.6 2.4(0.9-6.4) 2.9(1.1-7.6) 8(6.1) 0 0.0 0(0-0) 0(0-0)
 HPV45 15(7.1) 1 1742.5 0.6(0.1-4.1) 0.7(0.1-4.9) 7(5.3) 0 0.0 0(0-0) 0(0-0)
 HPV51 30(14.2) 5 1582.8 3.2(1.3-7.6) 3.8(1.6-9.1) 15(11.4) 2 1113.2 1.8(0.4-7.2) 2.2(0.5-8.6) 1.8(0.3-18.5) 0.53
 HPV52 16(7.6) 7 1683.2 4.2(2-8.7) 5(2.4-10.4) 17(12.9) 0 0.0 0(0-0) 0(0-0)
 HPV56 9(4.3) 3 1784.6 1.7(0.5-5.2) 2(0.6-6.2) 2(1.5) 0 0.0 0(0-0) 0(0-0)
 HPV58 25(11.8) 5 1607.4 3.1(1.3-7.5) 3.7(1.6-8.9) 9(6.8) 0 - - 0(0-0)
 HPV59 29(13.7) 10 1579.0 6.3(3.4-11.8) 7.6(4.1-14.1) 11(8.3) 0 - - 0(0-0)
 HPV68 21(9.9) 2 1656.4 1.2(0.3-4.8) 1.4(0.4-5.8) 10(7.6) 3 1161.0 2.6(0.8-8) 3.1(1-9.6) 0.5(0-4.1) 0.44

Any high-risk HPV 141(66.5) 13 457.7 28.4(16.5-48.9) 34(19.8-58.6) 67(50.8) 8 576.5 13.9(6.9-27.7) 16.6(8.3-33.2) 2(0.8-5.7) 0.056

HPV, human papillomavirus; CI, confidence interval; IRR, incidence rate ratio.